DisseminatedMycobacterium BovisInfection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder | Zendy

Fatehi Elzein | Zendy; Nada Albogami | Zendy; Mustafa Saad | Zendy; Nazik El Tayeb | Zendy; Abdullah Alghamdi | Zendy; Ghaleb Elyamany | Zendy

Open Access

DisseminatedMycobacterium BovisInfection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder

Author(s) -

Fatehi Elzein,

Nada Albogami,

Mustafa Saad,

Nazik El Tayeb,

Abdullah Alghamdi,

Ghaleb Elyamany

Publication year - 2016

Publication title -

clinical medicine insights case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.187

H-Index - 12

ISSN - 1179-5476

DOI - 10.4137/ccrep.s39904

Subject(s) - medicine , pancytopenia , transitional cell carcinoma , mycobacterium bovis , cystoscopy , pneumonitis , sepsis , urinary bladder , pathology , bone marrow , surgery , urinary system , tuberculosis , lung , mycobacterium tuberculosis , bladder cancer , cancer

Intravesical instillation of Bacillus Calmette-Guérin (BCG) remains a first-line treatment for superficial transitional cell carcinoma of the bladder. Although its use is relatively safe, severe complications such as granulomatous hepatitis, osteomyelitis, pneumonitis, and sepsis occur in few patients. Complications of intravesical instillation of BCG can be local or systemic, with early or late presentation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research